相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer
Muhammad M. Qureshi et al.
SURGERY (2023)
Disparities in esophageal cancer care based on race: a National Cancer Database analysis
Ikenna C. Okereke et al.
DISEASES OF THE ESOPHAGUS (2022)
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial
Karyn A. Goodman et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer
Aaron U. Blackham et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
The Impact of Pathological Tumor Regression and Nodal Status on Survival and Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
Hiroshi Miyata et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
Bo Jan Noordman et al.
LANCET ONCOLOGY (2018)
Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort
Elena Elimova et al.
ONCOLOGY (2018)
Prognostic significance of tumor regression in locally advanced rectal cancer after preoperative radiochemotherapy
Mirko Omejc et al.
RADIOLOGY AND ONCOLOGY (2018)
Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients
Hideomi Yamashita et al.
RADIATION ONCOLOGY (2017)
Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy
Kotaro Yamashita et al.
WORLD JOURNAL OF SURGERY (2017)
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy
Pamela Samson et al.
ANNALS OF THORACIC SURGERY (2016)
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
Elizabeth C. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma
Raed M. Alnaji et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
Extent of Lymph Node Removal During Esophageal Cancer Surgery and Survival
Maartje van der Schaaf et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Extent of Lymph Node Removal During Esophageal Cancer Surgery and Survival
Maartje van der Schaaf et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage
J. M. Findlay et al.
ANNALS OF ONCOLOGY (2015)
Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis
Fausto Petrelli et al.
EUROPEAN UROLOGY (2014)
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
Christophe Mariette et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response A phase 2 study
Felice Pasini et al.
CANCER (2013)
Epidemiology of esophageal cancer
Yuwei Zhang
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis
Qing Zhao et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2012)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Esophagus: ERCC1 Gene Polymorphisms for Prediction of Response and Prognosis
Ralf Metzger et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal Cancer
Kenneth L. Meredith et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival
James M. Donahue et al.
ANNALS OF THORACIC SURGERY (2009)
ERCC1 and XRCC1 Gene Polymorphisms Predict Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer
Ute Warnecke-Eberz et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
The National Cancer Data Base: A powerful initiative to improve cancer care in the United States
Karl Y. Bilimoria et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: An International Study on the Impact of Extent of Surgical Resection
Christian G. Peyre et al.
ANNALS OF SURGERY (2008)
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer
Xifeng Wu et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
AC Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)
SG Swisher et al.
ANNALS OF SURGERY (2005)
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
LR Chirieac et al.
CANCER (2005)
Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: Final results of a minnie pearl cancer research network phase II trial
AA Meluch et al.
CANCER JOURNAL (2003)
分享论文
